NCT01496157View on ClinicalTrials.gov

Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 11, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

September 17, 2017

Conditions
Prostate Cancer
Interventions
DRUG

18F-DCFBC

A bolus of 10 mCi (370 MBq) \[9-11 mCi (333-407 MBq)\] of 18F-DCFBC will be injected into the IV line by slow IV push.

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT01496157 - Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer | Biotech Hunter | Biotech Hunter